Organ Preservation Market share research by applications and regions for 2017-2024
Organ Preservation Market size is projected to experience significant growth from 2017 to 2024.Organ preservation market size should foresee significant growth due to consistent increase in the demand for body part transplantation over the last few years. The successful survival and high success rates of transplanted body parts including liver, kidney, and heart has elevated the global demand for transplantation surgeries.
Request for an in-depth table of contents for this report @ https://www.gminsights.com/request-toc/upcoming/1966
Transplantation is the only available procedure for the patients with end-stage organ failure. Increasing incidences of kidney, hearth, and lung failure will fuel the demand. The risk of failures further rises with the increasing age and presence of various clinical condition including diabetic nephropathy and cardiovascular diseases. According to the Australian Government, Department of Health, in 2014 around 203,400 Australians reported to have kidney disease out of which 10,143 people received kidney transplant.
Growing government initiatives to promote the body part donation to bridge the demand and supply gap will influence the organ preservation market size over the forecast period. Mass communication methods targeting the people to educate them about the donation of body parts is most common method that will increase the number of donations in future. Moreover, several technological advancements coupled with the increasing disposable income will further fuel the business growth.
Make an inquiry for buying this report @ https://www.gminsights.com/inquiry-before-buying/1966
R&D focused at developing alternatives to the transplantation will act as a restraint. For instance, efforts are being taken to develop the organs for transplantation from stem cells. The advent of 3D bioprinting technologies to develop human body parts such as heart, brains and arteries will act as a barrier. The limited number of donors coupled and excessive cost pertaining to the transplantation procedure may further limit the growth.
UW solution, developed by University of Wisconsin through the experiments designed to understand organ damage, is the most widely used solution for the body part preservation. The solution is applicable in the preservation of kidney, liver, pancreas and heart. However, the potential disadvantages such as poor initial perfusion of the graft and excessive cost associated with the use of UW solution can hinder the product share.
Kidney transplantation segment will show the robust growth due to the high number of kidney transplantation procedures. As per the National Institute of Diabetes and Digestive and Kidney Diseases, in 2013, around 47,000 Americans died of kidney diseases. Increasing incidences of chronic kidney diseases leading to the kidney failure will fuel the need for preservation solutions.
Static cold storage is most widely used technique. The reason behind this widespread use can be attributed to the favorable transport requirement and ideal organ quality. However, hypothermic machine perfusion technique will show a robust growth in the coming years due to the advantages such as improved preservation, ex-vivo conditioning of the graft and continuous graft evaluation.
U.S. will witness significant growth over the forecast period due increasing incidences of organ failures including kidney, heart and liver failure. As per the National Kidney Foundation, in 2013, around 26 million American have chronic kidney diseases. U.S. population shows positive attitude towards body part donation and consider it as an altruistic act which will further have positive impact on organ preservation market.
Some of the industry players are Essential Pharmaceuticals, Waters Medical System, Dr. Franz Kohler Chemie, XVIVO Perfusion, Organ Recovery Systems, Bristol-Myers Squibb, BioLifeSolutions, and 21st Century Medicine. The companies are adopting organic as well as inorganic growth strategies including strategic alliance and new product launch to garner higher market share. For instance, in January 2016, a newly developed PrimECC product from Xvivo Perfusion recieved CE mark approval.